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Poxvirus in West African nonhuman primates : 
serological survey results * 
J. G. BREMAN,I J. BERNADOU,2 & J. H. NAKANO 
Ten species of nonhuman primates in West African habitat were analysed for variola- 
vaccinia subgroup Iiaeinagglutinatioii-inhibition ( H I )  and neutralization antibodies. The 
aiiinials were taken in 27 different sampling zones in parts of the Ivory Coast, Mali, and 
Upper Volta. Of the I95 tested, I5 (8 %) had elevated HI antibodies after iionspecijîc 
reactions were reduced with potassium periodate pretseatinent. Positive neutralization 
antibodies were found in 21 % (44 of 206). Antibodies were detected in serum froin monkeys 
living near two areas where monkeypox cases in hummis had occurred. Foiir sainples were 
tested for monkeypox specific antibodies using aia indisect irnmuiio~uosescent test ; 3 were 
positive. Despite the prevalence of poxvirus antibodies iii monkeys (and other animals) in 
West Africa, sniallpox eradication has been maintairied in the area since I970 ; thus, animal 
reservoirs of poxvisia appear to pose iio threat to the worldwide sinallpox eradication 
programme. 
I 
l Monkeypox virus was first isolated in 1958, from 
disease in Denmark ( I ) .  Nine subsequent outbreaks 
have occurred in nonhuman primate populations in 
the USA, the Netherlands, and France (2, 3). Since 
monkeypox was identified in mañ in the tropical rain 
forest of the Republic of Zaire in 1970 (4) and in 
4 other countries of West Africa in 1971 (5, 6), vari- 
ous attempts have been made to link a nonhuman 
primate reservoir to human cases. 
Serum samples from 2242 monkeys of several 
species from various parts of Africa and Asia were 
tested by different laboratories for neutralization 
antibodies to variola-vaccinia antigen (7). No serum 
was felt to contain significant neutralization anti- 
I captive Cynomolgus monkeys with exanthematous 
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body. A survey of 100 Indian rhesus monkeys failed 
to detect either haemagglutination-inhibition (HI) or 
neutralization poxvirus antibodies (8). Other studies 
have shown significant variola-vaccinia group neutra- 
lization antibodies in serum of monkeys associated 
with humans with smallpox (9) and in the vicinity 
of humans with monkeypox (6, IO, I I ) .  
To define possible nonhuman primate reservoirs 
of poxviruses in West Africa, surveys were carried 
out in areas where these primates were known to live 
naturally. These areas of West Africa are within the 
general geographical zone where human monkeypox 
cases occurred (5, 6). 
MATERIALS AND METHODS 
, The survey used serum samples collected in a study 
to define the presence of yellow fever virus circulating 
in monkey populations in member countries of the 
Organisation de Coordination et de Coopération 
pour la lutte contre les GrandesEndémies (0CCGE)G 
between January 1973 and May 1974. 
A map of West Africa was divided into degrees by 
parallels (latitudes) and meridians (longitudes) 
(Fig. 1). A hunter (J. B.) was employed to shoot wild 
primates in 1 or 2 square degrees per month. Each 
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square degree contains approximately 12 100 km2. 
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. Fig. 1. Geographical distribution of orthopoxvirus antibodies in nonhuman primates. 
Primates were shot in 27 square degrees comprising 
about 327000 km2, containing parts of the Ivory 
Coast, Mali, and Upper Volta. Some zones bordered 
Ghana, Guinea, and Liberia. Primates were found 
in 2 major bioclimatic zones: the forest and heavily 
wooded preforest (5ON-8"N); and the savanna 
Immediately after shooting a monkey, the hunter 
identified and inspected the animal for age (young, 
young adult, adult, old), sex, and gross superficial 
lesions. He drew blood by aseptic heart puncture. 
This was allowed to clot under refrigeration for less 
than 24 hours. Serum was centrifuged and then 
poured into a sterilized glass vial containing 
4-5 drops of a solution containing penicillin, strepto- 
mycin, colistin (Colymycin), and kanamycin. Serum 
samples were frozen at -2O"C, packed in dry ice, 
and sent by air to the Center for Disease Control, 
Atlanta, for testing. 
(8"N-15""). 
HI antibodies to vaccinia antigen were measured 
at the Viral Exanthems Branch, Virology Division, 
Center for Disease Control, by the microtitration 
technique of Hierholzer & Suggs (12, 13) and neu- 
tralization antibodies by a plaque reduction method 
(14). An HI antibody titre of 210 (reciprocal of the 
dilution) and a neutralization antibody titre of 2 4  
were considered positive. If the HI test was positive 
or enough serum was available, the test was repeated 
after the serum had been treated with potassium per- 
iodate (KI03 to rule out a nonspecific reaction (15). 
A subsample of serum that was HI- or neutral- 
ization-positive was tested for monkeypox antibody 
with an indirect immunofluorescence test (16). 
RESULTS 
A total of 246 primates from 10 savanna- and 
forest-dwelling species were shot (Table 1); 56% of 
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these were savanna-dwelling African green monkeys 
(Cercopithecus aethiops) . No animal was noted to 
have external lesions consistent with a poxvirus 
disease. 
Sera from 206 animals were tested for HI and 
neutralization antibodies (Table 2); 43% (89/206) 
had HI antibodies, but only 8% (15/195) were posi- 
tive after KIO,, pretreatment. Fourteen of 15 HI-posi- 
tive serum samples were from Cercopithecus monkeys 
(Table 3) .  Only 6 of these 15 sera had detectable 
neutralization antibodies. Eleven of the HI-positive 
serum samples were from forest-dwelling monkeys. 
Monkeys were about equally divided by sex. Female 
monkeys with significant HI-antibody levels pre- 
dominated over males, l l  to 4 (Table 3); 21% 
(44/206) of the primates had detectable neutraliz- 
ation antibodies. Animals with neutralization anti- 
bodies were equally divided between sexes. Among 
young monkeys only 11% had neutralization anti- 
bodies, whereas 27% of adults had neutralization 
antibodies. No sex-related differences in neutraliz- 
ation antibody prevalence was observed. 
Fig. 2 indicates the distribution of the titres of 
animals with positive neutralization antibodies. 
Colobus monkeys had higher neutralization titres 
than Cercopithecus monkeys. Younger monkeys, if 
positive, tended to have higher neutralization titres 
than older specimens. 
Table 1. Wild primates killed in West Africa a 
Genus and species No. killed Common name Habitat and habits 
Cercopithecus 
C. aethiops 
C. mona 
C. petaurista 
C. diana 
C. nictitans 
genus total 
Colobus 
C. badius 
C. polykomos 
C. verus 
genus total 
Erythrocebus patas 
Papi0 anubis 
137 
37 
31 
10 
5 
220 
15 
1 
1 
17 
5 
4 
Arboreal and diurnal: all forest strata colonized 
except floor; groups of 40-50 composed of 
families of 4-5; species geographically 
associated: mav be escorted bv birds (hornbills. 
parrots); remain in one area’; sedentary; eat 
vegetable matter supplemented by insects, 
birds, eggs; gestation 130 days (single birth) ; 
longevity about 20 years: predators large 
birds (crowned eagle), carnivores 
Grivet or green monkey Savanna and woodland (preforest) ; open 
country; forest gallery ?o sleep; bands of 
6-20; mix with C. petaumta 
Mona monkey Forest and galleries; lower and middle strata 
Lesser white-nosed Forest, fringe savanna ; lower forest canopy 
monkey 
Diana monkey 
Greater white-nosed 
Dense forest; upper strata 
Forest, wooded savanna; high galleries; mix 
monkey with C. mona 
Arboreal; forest: troops of up to 25;  eat 
leaves; coat highly prized by hunters 
Forest; upper strata 
High forest; fringe savanna 
Western red colobus 
Western black and 
white colobus monkey 
Olive colobus monkey High forest; thickets and lower strata: bands 
of 6-20; mix with C. mona and C. petaurista; 
eat leaves; mother carries young in mouth 
Patas or red monkey Savanna; open country; very terrestrial; bands 
of 9-30; range up to 50 km2; no mixing: 
vegetable matter; gestation 160 days. 
Anubis baboon Savanna 
total 246 
a Modified from Dorst 8, Dandelot (20). 
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Table 2. Variola-vaccinia antibodies found in wild primates 
HI a Neutralization 
No. No. ss. No. No. %. Species tested positive positive tested positive positive 
Cercopithecus aethiops 99 4 4 1 o1 25 25 
C. mona 29 3 10 33 6 18 
C. petaurista 31 5 16 31 6 19 
C. diana 6 . I  17 10 O O 
C. nictitans 5 1 20 5 1 20 
genus total 170 14 8 180 38 21 
Colobus badius 15 1 7 15 5 33 
C. polykomos O - - 1 1 1 O 0  
C. verus 1 O O 1 O O 
genus total 16 1 6 17 6 35 
Erythrocebus patas 5 O O 5 O O 
Papi0 anubis 4 O O 4 O O 
total 195 15 8 206 44 21 
a89 of 206 were HI positive; these 195 were tested again after being treated with Klo& 
Table 3. Monkeys with positive HI titres 
Species Number Zone Age a Sex HI Neutralization 
Cercopithecus aethiops 
Cercopithecus diana 
Colobus badius 
Cercopithecus nictitans 
Cercopithecus petaurista 
Cercopithecus aethiops 
Cercopithecus petaurista 
Cercopithecus mona 
334 
344 
346 
503 
51 1 
530 
638 
541 
387 
557 
575 
577 
582 
581 
559 
74 
75 
75 
77 
77 
87 
98 
98 
107 
108 
717 
117 
117 
117 
118 
A 
A 
A 
A 
A 
A 
YA 
A 
A 
YA 
A 
' Y  
YA 
A 
A 
F 
M 
M 
F 
F 
F 
M 
F 
M 
F 
F 
F 
F 
F 
F 
40 
10 
20 
10 
10 
10 
40 
20 
20 
40 
10 
40 
20 
40 
80 
4 
< 4  
4 
< 10 
< 10 
50 
< 4  
< 4  
< 4  
< 4  
250 
450 
< 4  
< 4  
1 O0 
a A - adult, Y - young. 
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Table 4. Titres on serum tested for variola-vaccinia group and monkeypox antibodies 
Monkey 
IF Titrea 
After absorption 
tion b with vaccinia against with monkeypox against 
No. Zone HI 0 Neutraliza- After 
Vaccinia Monkey- Vaccinia Monkey- 
POX POX 
Colobus badius 492 89 1 5  2500 < a  8 < %  < %  
Cercopithecus petaurista 576 11 7 5 450 < %  64 < %  < %  
Cercopithecus petaurista 577 117 40 450 . < %  64 1% < %  
a Rijks lnstituut voor de Volksgezondheid 
b Center for Disease Control 
Four specimens were tested for specific monkey- 
pox antibodies. Three were positive (Table 4). These 
3 animals were found in zones within 200 km o€ areas 
where human monkeypox cases had occurred. 
The geographical distribution of monkeys with 
positive antibodies is shown in Fig. 1. The highest 
concentration of positive animals was in heavily 
wooded savanna and the forest. 
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Fig. 2. Neutralization antibody titres in nonhuman 
primates. 
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DISCUSSION 
These serological surveys indicate that both sav- 
anna- and forest-dwelling Cercopithecus and forest- 
dwelling Colobus monkeys in West Africa have been 
infected with a poxvirus, probably an Orthopoxvirus, 
the subgroup containing variola, vaccinia, monkey- 
pox, and whitepox. Monkeypox infections have oc- 
curred in species of both Cercopithecm and Colobus. 
The finding that, of the HI-positive sera, only 6 had 
neutralization antibody is difficult to explain. It is 
unlikely that these other 9 monkeys had had a recent 
poxvirus infection but the possibility cannot be 
categorically excluded. Neutralization antibody was 
undetectable at 33 days after human smallpox infec- 
tion when HI, complement fixing, and radioimmu- 
noassay antibodies to vaccinia were present (17). 
Neutralization antibody was not observed 73 days 
after a primary vaccination when HI and comple- 
ment fixing antibodies became elevated (Nakano, 
J. H., personal communication, 1977); however, 
these are exceptions. 
It is possible that the more elevated HI titres re- 
present relatively recent infections. HI antibody 
titres rise and fall more rapidly than neutralization 
or complement-fixing antibody titres in experimental 
monkeys infected with monkeypox virus (18). These 
experimental monkeys developed HI titres of be- 
tween l : 640 and l : 1280 at 21 days which dropped 
to a mean of 1 : 30 at 6 months. In the present study 
only 1 animal with HI antibodies was considered 
young, so we cannot conclude that these infections 
are usually acquired at an early age. The relationship 
of antibody level and maintenance of a poxvirus 
infection is still unclear. A variola-like virus isolated 
from the kidney of a healthy chimpanzee found in the 
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Republic of Zaire (10) was associated with an HI titre 
of 1 : 1280 and a neutralization titre of 1 : >40 (19), 
indicating that premunition does occur. 
It is difficult to estimate the type and intensity of 
contact these monkeys have with humans. In many 
of these areas, nonhuman primates are captured and 
kept as pets. They are also shot for food and are 
often considered a culinary delicacy. Skins of Colobus 
monkeys are used to make cloaks and other regalia 
for tribal ceremonies. While nonhuman primates usu- 
ally stay away from major population centres, they 
frequently take food from fields under cultivation. 
A human monkeypox case in eastern Liberia 
{zone 66) (5) occurred less than 50 km from Guiglo 
Department (Toulepleu region, zone 66) in the Ivory 
Coast, where 3 of 6 Colobus badilrs monkeys had 
neutralization antibodies, and less than 200 km from 
a zone where monkeypox-specific antibody was 
found in the same species. A Cercopithecus mona 
monkey with neutralization antibodies was captured 
in Abengourou Department (Agnibilekrou region, 
zone Ils), near the area (zone 119) where a case of 
human monkeypox was associated with positive 
neutralization titres in serum from Cercopithectis 
mona, C. diana, and C. petativista as well as from 
rodents, larger mammals, and birds (6). The 2 C. 
petarirista with monkeypox-specific antibodies were 
found within 200 km of where this human monkey- 
pox case occurred. These forest-dwelling monkey 
populations may share the same arboreal habitats 
(20) ; they have been observed mixing together. Small 
mammals such as rodents pass under primates and, 
if susceptible, could conceivably become infected by 
this association. The potential wide host range of 
monkeypox virus was demonstrated in the Nether- 
lands, where a strain, isolated from anteaters and 
monkeys, was transmitted to rabbits and suckling 
mice (21). 
It seems obvious that a reliable serological test that 
could distinguish the various poxviruses would be an 
important epidemiological tool for poxvirus research. 
The immunofluorescent test using cross-absorbed 
antigen is the most promising recent development in 
this field. 
Isolating monkeypox virus and other poxviruses 
from wild animals would be helpful in defining the 
epidemiology of these viruses, however, experience 
has been that a great number of animals would have 
to be captured in order to isolate even a few viruses. 
More information is needed on the possible contacts 
that wild animals with evidence of prior monkeypox 
infection have with human populations as well as on 
associations between animals of the same and other 
species. 
Despite the evidence of recent and past poxvirus 
infections among different animal populations in this 
zone. there is little reason to think that the world- 
wide smallpox eradication programme is endangered. 
There have been only 20 known cases of monkeypox 
in humans in West and Central Africa; all have oc- 
curred since 1970 (22). All but one of the outbreaks 
have been observed in forest villages of less than 
300 persons. Person-to-person transmission occurs 
with difficulty. Only two secondary cases of human 
monkeypox among intimately exposed family con- 
tacts have been reported. The 6% secondary attack 
rate for susceptible persons in contact with human 
monkeypox is much less than that of classic smallpox, 
which ranges between 35% and 45%. Even after the 
mass vaccination campaigns, the West and Central 
African population has never been much more than 
80% immune to smallpox, an immunity that appears 
to protect also against monkeypox. During 1975 and 
1976 the health ministries of 15 countries in West and 
Central Africa did extensive facial pock-mark surveys 
in humans to detect cases of poxvirus disease that 
may have occurred since the last case of smallpox was 
confìrmed in the area in 1970 (23). In a population 
of 124 600 000, a total of 6 497 250 persons were 
examined; 1 631 918 were preschool children, most 
born since 1970. None of these persons had facial 
pock-marks due to poxvirus.a It was estimated that 
less than 50% of the preschool children had smallpox 
vaccination scars. As the rural forest and savanna 
populations had regular contact with nonhuman pri- 
mates as well as with other animals with poxvirus 
antibodies, more human cases due to monkeypox or 
other Orthopoxviriises would be expected if these 
viruses had an affinity for man. Large numbers of 
human cases have not been found despite intensified 
surveillance for human poxvirus disease since 1970. 
ADDENDUM 
Since this paper was prepared, it has been reported 
that variola, monkeypox, and vaccinia antisera can 
be differentiated by solid-phase radioimmunoassay 
after adsorption of the antisera with “ homologous ” 
and “ heterologous ” poxvirus-infected membranes 
(Hutchinson, H. D. et al., see thisissuepages 613-623). 
a Report of the WHO International Commission for Cer- 
tification of Smallpox Eradication from West Africa, 1976, 
Abidjan-Brazzaville, 23 March-15 April 1976 (Unpublished 
WHO (AFRO) document ICP SMEO O 1  Afr/Smallpox/SO). 
I 
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RGSUMB 
LES POXVIRUS CHEZ LES PRIMATES D’AFRIQUE OCCIDENTALE: RÉSULTATS D’UNE ENQUÊTE SÉROLOGIQUE 
Des primates ont été capturés et saignés dans leur 
habitat naturel en Afrique occidentale, et la fréquence 
des anticorps contre les poxvirus dans leur sérum a été 
étudiée. Cette étude était destinée à déterminer la distri- 
bution des anticorps anti-poxvirus chez les primates dans 
une vaste région géographique à proximité de secteurs 
où des cas d’infections humaines à monkeypox s’étaient 
produits. On visait ainsi à évaluer la possibilité que des 
poxvirus trouvés chez l’animal puissent causer une 
maladie humaine ressemblant à la variole. 
On a éprouvé 10 espèces de primates par les réactions 
d’inhibition de I’hémagglutination (IH) et de neutralisa- 
tion afin de rechercher dans leur sérum des anticorps 
contre les virus du sous-groupe variole-vaccine. On a cap- 
turé 246 animaux, dont 56% étaient des Cercopithecus 
aethiops habitant la savane africaine. Ces animaux ont 
été pris dans 27 zones d’échantillonnage différentes en 
Côte d’Ivoire, aw Mali et en Haute-Volta. Sur les 195 ani- 
maux éprouvés, 15 (8%) présentaient des titres élevés 
d’anticorps inhibant I’hémagglutination après réduction 
des réactions non spécifiques par prétraitement au perio- 
date de potassium. Parmi les échantillons de sérum 
IH-positifs, 14 provenaient de Cercopithecus et 11 de 
singes habitant la forêt. Une proportion de 21 % (44-206) 
des primates possédaient des anticorps neutralisants 
décelables. Les titres de ces anticorps étaient plus élevés 
chez les singes Colobus que chez les cercopithèques. Des 
anticorps ont été décelés dans le sérum de singes habitant 
à proximité de deux secteurs, l’un au Liberia et l’autre 
en Côte d’Ivoire, oh des cas humains d’infection à mon- 
lteypox s’étaient produits. On a soumis 4 échantillons 
à une épreuve d’immunofluorescence indirecte en vue d’y 
rechercher les anticorps spécifiques du monkeypox; 3 de 
ces sérums étaient positifs et ils provenaient d’animaux 
capturés dans des zones situées à moins de 200 km de 
secteurs oÙ des cas humains de monkeypox s’étaient pro- 
duits. La plus haute concentration d’animaux positifs a été 
trouvée dans la savane fortement boisée et dans la forêt. 
Ces enquêtes sérologiques indiquent qu’en Afrique occi- 
dentale les cercopithèques de la savane comme de la 
forêt et les Colobus de la forêt ont été infectés par un 
poxvirus, probablement un Orthopoxvirus, sous-groupe 
comprenant les virus de la variole, de la vaccine, du 
monkeypox et du whitepox. Les infections à monkeypox 
se sont produites chez des espèces de Cercopithecus et 
de Colobus. Malgré la fréquence des anticorps anti-pox- 
virus chez les singes et d’autres animaux en Afrique occi- 
dentale, I’éradication de la .variole a été maintenue dans 
cette région depuis 1970. De vastes enquêtes visant à 
rechercher des cicatrices faciales de variole ont été effec- 
tuées en 1975 et 1976 par les ministères de la santé de 
quinze pays d’Afrique occidentale et centrale, mais elles 
n’ont pas permis de détecter des indices de variole surve- 
nue dans cette zone depuis 1970. Ainsi, les réservoirs ani- 
maux de poxvirus ne semblent pas constituer de menace 
pour le programme d’éradication mondiale de la variole. 
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